Сравнение

Ganirelix vs. Octreotide

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

123246-29-7

83150-76-9

Молекулярная масса

1570.3 g/mol

1019.24 g/mol

Период полувыведения

нет данных

1.7 h

Последовательность

нет данных

D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr(ol)

Механизм действия

Ganirelix

Ganirelix competitively and reversibly binds the pituitary GnRH receptor, rapidly suppressing LH (and, less so, FSH) release — without the initial hormone 'flare' of GnRH agonists.

Octreotide

Octreotide is a cyclic octapeptide that selectively binds somatostatin-receptor subtypes SSTR2 and SSTR5. Via G-protein-coupled signalling, adenylyl cyclase is inhibited, reducing the secretion of multiple hormones (growth hormone, IGF-1, glucagon, insulin, VIP, serotonin). Structural stabilisation via a disulfide bridge and D-amino acids extends the half-life relative to natural somatostatin (minutes to several hours).

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Ganirelix	Octreotide
Германия	Рецептурный	Рецептурный
США	Рецептурный	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Ganirelix and Octreotide?: Ganirelix is classified as "Исследования (прочее)", while Octreotide is classified as "Исследования (прочее)". Ganirelix: Ganirelix is a synthetic decapeptide and GnRH antagonist. In assisted reproduction (IVF) it prevents the premature LH surge during controlled ovarian stimulation. Octreotide: Synthetic octapeptide somatostatin analog with a longer half-life than endogenous somatostatin. FDA- and EMA-approved since the 1980s for acromegaly and neuroendocrine tumours. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Ganirelix or Octreotide?: The highest available evidence level is "РКИ на людях" for Ganirelix and "РКИ на людях" for Octreotide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Ganirelix and Octreotide in Germany and the United States?: Германия: Ganirelix — Рецептурный, Octreotide — Рецептурный. США: Ganirelix — Рецептурный, Octreotide — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Ganirelix

Octreotide

Германия

Рецептурный

США

Рецептурный

Frequently asked questions

What is the difference between Ganirelix and Octreotide?

Ganirelix is classified as "Исследования (прочее)", while Octreotide is classified as "Исследования (прочее)". Ganirelix: Ganirelix is a synthetic decapeptide and GnRH antagonist. In assisted reproduction (IVF) it prevents the premature LH surge during controlled ovarian stimulation. Octreotide: Synthetic octapeptide somatostatin analog with a longer half-life than endogenous somatostatin. FDA- and EMA-approved since the 1980s for acromegaly and neuroendocrine tumours. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Ganirelix or Octreotide?

The highest available evidence level is "РКИ на людях" for Ganirelix and "РКИ на людях" for Octreotide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Ganirelix and Octreotide in Germany and the United States?

Германия: Ganirelix — Рецептурный, Octreotide — Рецептурный. США: Ganirelix — Рецептурный, Octreotide — Рецептурный. These are factual summaries with source and review date on the individual pages.